Clinical trial
Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in…
NCT00309530 · Austrian Breast & Colorectal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00309530 |
|---|---|
| Title | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C |
| Official title | A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0). |
| Lead sponsor | Austrian Breast & Colorectal Cancer Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colon Cancer Stage III |
| Intervention type | Drug |
| Interventions | 5-fluorouracil, levamisol, interferon |
| Enrollment | 598 |
| Start date | Oct 1, 1990 |
| First posted | Apr 3, 2006 |
| Last update posted | Apr 3, 2006 |
| Countries | Austria |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: